Stock Alert: Cardiovascular Systems (CSII) Trades 5.19% Higher June 23

Equities Staff  |

Cardiovascular Systems Inc. (NASDAQ:CSII) stock was among today's market movers, ending trading higher 5.19% to $14.59 on June 23.

340,890 shares were traded today while the 30-day daily average of 357,874 shares.

The company's stock has risen 26.14% so far in 2022.

Cardiovascular Systems shares have fluctuated between $13.41 and $44.57 over the past twelve months.

The company expects its next earnings on 2022-08-04.

For technical charts, analysis, and more on Cardiovascular Systems visit the company profile.

About Cardiovascular Systems Inc.

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company's orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.

To get more information on Cardiovascular Systems Inc. and to follow the company's latest updates, you can visit the company's profile page here: Cardiovascular Systems Inc.'s Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks
Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade



Market Movers

Sponsored Financial Content